Long-Term Organ Preservation in Rectal Cancer Is Possible

Long-term data from the OPRA trial show organ preservation at 5 years in about half of patients with stage II/III rectal adenocarcinoma who received total neoadjuvant therapy.
Medscape Medical News

source https://www.medscape.com/viewarticle/998830?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?